Jin Xiang
Chengdu, 610441, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Efficacy and Safety of Aurantii Fructus Immaturus Flavonoid Tablets in Patients with Functional Dyspepsia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial.
Journal: Chinese journal of integrative medicine
Published: January 22, 2025
Preclinical and first-in-human of purinostat mesylate, a novel selective HDAC I/IIb inhibitor, in relapsed/refractory multiple myeloma and lymphoma.
Journal: Signal transduction and targeted therapy
Published: October 02, 2024
Neutrophil-to-Lymphocyte Ratio as a Predictor for PD-L1 Inhibitor Treatment in Recurrent or Metastatic Nasopharyngeal Carcinoma.
Journal: Head & neck
Published: March 31, 2024
Association Study of Esomeprazole Pharmacokinetics and CYP2C19 Gene Polymorphisms.
Journal: Clinical pharmacology in drug development
Published: June 24, 2023
Pharmacokinetic and bioequivalence of lenalidomide in multiple myeloma patients.
Journal: International journal of clinical pharmacology and therapeutics
Published: January 23, 2023
Trend of clinical trials of new drugs for rare diseases in China in recent 10 years.
Journal: Orphanet journal of rare diseases
Published: January 16, 2023
Aldehyde dehydrogenase 2-associated changes in pharmacokinetics, locomotor function and peripheral glutamic acid and gamma-aminobutyric acid levels during acute alcohol intoxication in male mice.
Journal: Behavioural pharmacology
Published: October 18, 2022
Recent progress in DNA methyltransferase inhibitors as anticancer agents.
Journal: Frontiers in pharmacology
Published: October 17, 2022
Lipidomic changes of cerebral cortex in aldehyde dehydrogenase-2 knock-in heterozygote mice after chronic alcohol exposure.
Journal: Frontiers in molecular neuroscience
Published: September 25, 2022
Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study.
Journal: Eye (London, England)
Published: August 18, 2022
High-Throughput mRNA Sequencing Reveals Potential Therapeutic Targets of Febuxostat in Secondary Injury After Intracerebral Hemorrhage.
Journal: Frontiers in pharmacology
Published: December 12, 2021
Last Updated: 09/26/2026